January 24, 2023 03:26 PM ESTUpdated 04:06 PM
Pharma
Marketing

Pfiz­er taps Pink, Michael Phelps and oth­er celebri­ties in lat­est Covid cam­paign

Nicole DeFeudis

Editor

First, it was Martha Stew­art. Now, four more celebri­ties who are at high risk for de­vel­op­ing se­vere Covid-19 symp­toms are get­ting in on Pfiz­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

As­traZeneca is de­nied full FDA ap­proval of An­dexxa fol­low­ing crit­i­cal ad­vi­so­ry meet­ing

Roche ter­mi­nates a Phase 3 Spark gene ther­a­py in he­mo­phil­ia A

Bi­cy­cle Ther­a­peu­tics stock sinks fol­low­ing re­lease of topline da­ta, post-hoc analy­ses

Bris­tol My­ers drops cell ther­a­py pacts with Im­mat­ics, Cen­tu­ry as part of port­fo­lio re­view

Check­point wins FDA ap­proval of check­point in­hibitor in ad­vanced skin can­cer, seeks part­ner for launch

A service from the Financial Times